Literature DB >> 20440262

IGFBP7: an oncosuppressor gene in thyroid carcinogenesis.

M G Vizioli1, M Sensi, C Miranda, L Cleris, F Formelli, M C Anania, M A Pierotti, A Greco.   

Abstract

Insulin-like growth factor-binding protein 7 (IGFBP7) is a secreted protein involved in several cellular processes, including proliferation, senescence and apoptosis. Loss of IGFBP7 expression is a critical step in the development of human tumors, including melanoma and colon cancer. By microarray gene expression studies, we have detected downregulation of IGFBP7 gene expression in follicular and papillary thyroid tumors in comparison with normal thyroid tissue. Evaluation of publicly available PTC microarray gene expression data sets confirmed, in a consistent fraction of tumors, the downregulation of IGFBP7 transcript levels. The functional consequence of IGFBP7 downregulation was addressed in the PTC-derived NIM1 cell line in which IGFBP7 expression is repressed by promoter hypermethylation. Exposure to soluble IGFBP7 protein or restoration of IGFBP7 expression by complementary DNA transfection reduced growth rate, migration, anchorage-independent growth and tumorigenicity of NIM1 cells. We show that the effects of IGFBP7 are related to apoptosis. Our data suggest that loss of IGFBP7 expression has a functional role in thyroid carcinogenesis, and it may represent a possible basis for therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20440262     DOI: 10.1038/onc.2010.136

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  24 in total

1.  Relative quantification of serum proteins from pancreatic ductal adenocarcinoma patients by stable isotope dilution liquid chromatography-mass spectrometry.

Authors:  Angela Y Wehr; Wei-Ting Hwang; Ian A Blair; Kenneth H Yu
Journal:  J Proteome Res       Date:  2012-02-15       Impact factor: 4.466

2.  The functional IGFBP7 promoter -418G>A polymorphism and risk of head and neck cancer.

Authors:  Yu-Jing Huang; Jiangong Niu; Zhensheng Liu; Li-E Wang; Erich M Sturgis; Qingyi Wei
Journal:  Mutat Res       Date:  2010-07-03       Impact factor: 2.433

3.  Insulin-like growth factor binding protein 7 and tissue inhibitor of metalloproteinases-2: differential expression and secretion in human kidney tubule cells.

Authors:  David R Emlet; Nuria Pastor-Soler; Allison Marciszyn; Xiaoyan Wen; Hernando Gomez; William H Humphries; Seth Morrisroe; Jacob K Volpe; John A Kellum
Journal:  Am J Physiol Renal Physiol       Date:  2016-12-21

4.  STAT3 negatively regulates thyroid tumorigenesis.

Authors:  Joana Pinto Couto; Laura Daly; Ana Almeida; Jeffrey A Knauf; James A Fagin; Manuel Sobrinho-Simões; Jorge Lima; Valdemar Máximo; Paula Soares; David Lyden; Jacqueline F Bromberg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-13       Impact factor: 11.205

Review 5.  Insulin-like growth factor: current concepts and new developments in cancer therapy.

Authors:  Erin R King; Kwong-Kwok Wong
Journal:  Recent Pat Anticancer Drug Discov       Date:  2012-01       Impact factor: 4.169

6.  IGFBP-rP1, a potential molecule associated with colon cancer differentiation.

Authors:  Wenjing Ruan; Shuzhen Zhu; Haibing Wang; Fangying Xu; Hong Deng; Yu Ma; Maode Lai
Journal:  Mol Cancer       Date:  2010-10-26       Impact factor: 27.401

7.  Insulin-like growth factor-binding protein-7 (IGFBP7): a promising gene therapeutic for hepatocellular carcinoma (HCC).

Authors:  Dong Chen; Ayesha Siddiq; Luni Emdad; Devaraja Rajasekaran; Rachel Gredler; Xue-Ning Shen; Prasanna K Santhekadur; Jyoti Srivastava; Chadia L Robertson; Igor Dmitriev; Elena A Kashentseva; David T Curiel; Paul B Fisher; Devanand Sarkar
Journal:  Mol Ther       Date:  2013-01-15       Impact factor: 11.454

8.  Decreased expression of IGFBP7 was a poor prognosis predictor for gastric cancer patients.

Authors:  Long Liu; Zhihui Yang; Weixing Zhang; Bing Yan; Qunhao Gu; Jianpeng Jiao; Xiaoqiang Yue
Journal:  Tumour Biol       Date:  2014-06-04

9.  Majority of differentially expressed genes are down-regulated during malignant transformation in a four-stage model.

Authors:  Frida Danielsson; Marie Skogs; Mikael Huss; Elton Rexhepaj; Gillian O'Hurley; Daniel Klevebring; Fredrik Pontén; Annica K B Gad; Mathias Uhlén; Emma Lundberg
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-08       Impact factor: 11.205

10.  Sprouty1 induces a senescence-associated secretory phenotype by regulating NFκB activity: implications for tumorigenesis.

Authors:  A Macià; M Vaquero; M Gou-Fàbregas; E Castelblanco; J M Valdivielso; C Anerillas; D Mauricio; X Matias-Guiu; J Ribera; M Encinas
Journal:  Cell Death Differ       Date:  2013-11-22       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.